Metastatic bladder carcinoma
Clinical trials for Metastatic bladder carcinoma explained in plain language.
Never miss a new study
Get alerted when new Metastatic bladder carcinoma trials appear
Sign up with your email to follow new studies for Metastatic bladder carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a rheumatoid arthritis drug tame Immunotherapy's side effects?
Disease control OngoingThis study tests whether adding tocilizumab (a drug used for arthritis) to standard immunotherapy can reduce severe side effects in people with advanced melanoma, lung cancer, or bladder cancer. About 35 participants will receive all three drugs. The goal is to see if the combina…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Targeted drug shows promise for Hard-to-Treat bladder cancers
Disease control OngoingThis study tests a drug called olaparib in 60 people with advanced bladder or related cancers that have specific DNA repair defects. Olaparib blocks a protein that cancer cells need to fix their DNA, which may stop the cancer from growing. The goal is to see if the drug can shrin…
Matched conditions: METASTATIC BLADDER CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New support tool aims to ease bladder cancer care burden
Symptom relief OngoingThis trial tests a special education and navigation program for people with advanced bladder cancer and their caregivers. The program provides guidance, nutritional advice, and distress screening to help them better manage treatment decisions and care coordination. Researchers ho…
Matched conditions: METASTATIC BLADDER CARCINOMA
Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC